BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Auris Medical AG 

Falknerstrasse 4

Basel    4001  Switzerland
Phone: 41-61-201-13-50 Fax: 41-61-201-13-51


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Start Up





 Company News
Auris Medical AG (EARS) Q3 2014 Earnings Release 12/3/2014 12:22:33 PM
Auris Medical AG (EARS) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, December 3, 2014 12/1/2014 10:37:38 AM
Auris Medical AG (EARS) Reports Second Quarter 2014 Financial Results and Provides Business Update 9/15/2014 7:59:30 AM
Auris Medical AG (EARS) To Announce Second Quarter 2014 Financial Results And Host Conference Call On Monday, September 15, 2014 9/8/2014 10:23:32 AM
Auris Medical AG (EARS) Announces Exercise Of IPO Over-Allotment Option 8/20/2014 7:35:20 AM
Auris Medical AG (EARS) Announces Closing of Initial Public Offering 8/11/2014 11:47:40 AM
Auris Medical AG (EARS) Prices IPO At $6 A Share, Raises $56 Million 8/6/2014 7:00:36 AM
Auris Medical AG Commences Proposed Initial Public Offering Of Common Shares 7/21/2014 7:36:05 AM
Published Analysis Confirms Positive Results From Auris Medical AG's Phase 2b Study With AM-101 In Treatment Of Acute Inner Ear Tinnitus 3/31/2014 9:01:12 AM
Auris Medical AG Announces Enrollment Of First Patient In North American Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 3/10/2014 9:12:37 AM
12345